Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and EGFR-Mutated Lung Adenocarcinoma.

Subjects

Subjects :

Adenocarcinoma pathology
Adenocarcinoma of Lung
ErbB Receptors genetics
Female
Humans
Lung Neoplasms pathology
Middle Aged
Platinum therapeutic use
Protein Kinase Inhibitors pharmacology
Adenocarcinoma drug therapy
Lung Neoplasms drug therapy
Protein Kinase Inhibitors therapeutic use

Details

Language :

English

ISSN :

1556-1380

Volume :

12

Issue :

12

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Report

Accession number :

29169523

Full Text :

https://doi.org/10.1016/j.jtho.2017.07.034